Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Przemysław Kardas"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundAdherence to medications presents a significant challenge in healthcare. Statins, used in primary and secondary prevention of cardiovascular disease, are of particular importance for public health. The outbreak of the COVID-19 pandemic resu
Externí odkaz:
https://doaj.org/article/849b424ee2af42e9a0f7d2354e78e9e5
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Polypharmacy, defined as the simultaneous use of multiple medications by a patient, is a worldwide problem of rising prevalence. Paving the way for drug interactions, adverse drug reactions and non-adherence, it leads to negative health o
Externí odkaz:
https://doaj.org/article/628769d04e65440bb450a3248d68cc6d
Autor:
Kamila Urbańczyk, Sonja Guntschnig, Vasilis Antoniadis, Slaven Falamic, Tijana Kovacevic, Marta Kurczewska-Michalak, Branislava Miljković, Anna Olearova, Inese Sviestina, Attila Szucs, Konstantin Tachkov, Zita Tiszai, Daisy Volmer, Anna Wiela-Hojeńska, Daniela Fialova, Jiri Vlcek, Matej Stuhec, Anita Hogg, Michael Scott, Derek Stewart, Alpana Mair, Silvia Ravera, François-Xavier Lery, Przemysław Kardas
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcome
Externí odkaz:
https://doaj.org/article/24ae8b9d246140f4a906721e24e56ac4
Autor:
Przemysław Kardas, Martina Bago, Pilar Barnestein-Fonseca, Kristina Garuolienė, Anne Gerd Granas, João Gregório, Maja Ortner Hadžiabdić, Barbora Kostalova, Francisca Leiva-Fernández, Pawel Lewek, Katerina Mala-Ladova, Marie Paule Schneider, Job F. M. van Boven, Daisy Volmer, Ioli Ziampara, Tamás Ágh
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Medication non-adherence jeopardises the effectiveness of chronic therapies and negatively affects financial sustainability of healthcare systems. Available medication adherence-enhancing interventions (MAEIs) are utilised infrequently, a
Externí odkaz:
https://doaj.org/article/068597516ec943fba503264f9e6434e4
Autor:
Tamás Ágh, Maja Ortner Hadžiabdić, Kristina Garuoliene, Anne Gerd Granas, Emma Aarnio, Enrica Menditto, João Gregório, Pilar Barnestein-Fonseca, Vildan Mevsim, Przemysław Kardas, European Network to Advance Best Practices and Technology on Medication Adherence (ENABLE)
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Introduction: Current literature lacks detailed understanding of the reimbursement framework of medication adherence enhancing interventions (MAEIs). As part of the ENABLE COST Action, the EUREcA (“EUropen REimbursement strategies for interventions
Externí odkaz:
https://doaj.org/article/46290b8d358649518348117fb7c9097c
Autor:
Przemysław Kardas, Tamás Ágh, Alexandra Dima, Catherine Goetzinger, Ines Potočnjak, Björn Wettermark, Job F. M. van Boven
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 933 (2023)
Medication adherence is a key precondition of the effectiveness of evidence-based therapies. However, in real-life settings, non-adherence to medication is still very common. This leads to profound health and economic consequences at both individual
Externí odkaz:
https://doaj.org/article/277e128f7ff14b98843430f4a440662c
Publikováno v:
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract Background Treatment adherence greatly influences the clinical outcomes in various fields of medicine, including management of asthma and COPD. With the recent implementation of a nationwide e-Health solutions in Poland, new and unique oppor
Externí odkaz:
https://doaj.org/article/82b36cd196ca4094b68dc8229b169b1f
Publikováno v:
Family Medicine & Primary Care Review, Vol 22, Iss 1, Pp 27-31 (2020)
Externí odkaz:
https://doaj.org/article/98bf00b3453c408c92367065e1cf78bd
Autor:
Przemysław Kardas, Aneta Lichwierowicz, Filip Urbański, Ewa Chudzyńska, Marcin Czech, Grzegorz Kardas
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Multimorbidity often comes with age, making elderly people particularly prone to polypharmacy. Polypharmacy, in turn, is a risk factor for adverse drug reactions, drug-drug interactions, non-adherence to medication, negative health outc
Externí odkaz:
https://doaj.org/article/7e2dc330329c47088374f722920069e8
Autor:
Przemysław Kardas, Filip Urbański, Aneta Lichwierowicz, Ewa Chudzyńska, Grzegorz Kardas, Marcin Czech
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Polypharmacy is a risk factor for adverse health outcomes, higher use of medical services and additional costs. The problem has gained attention as a consequence of aging and related multimorbidity. Therefore, there is an urgent need to
Externí odkaz:
https://doaj.org/article/11415cd118d2474ab675874d8eb139eb